|
|
|
Insider
Information: |
Bailey Don M |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
699,357 |
|
Indirect Shares
|
329,463 |
|
|
Direct
Value |
$4,483,612 |
|
|
Indirect Value
|
$811,658 |
|
|
Total
Shares |
1,028,820 |
|
|
Total
Value |
$5,295,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Comarco Inc |
CMRO |
Chairman of the Board,... |
2006-02-06 |
64,188 |
2007-03-21 |
66,859 |
Premium* |
|
STAAR Surgical Co |
STAA |
Director |
2013-05-15 |
98,137 |
2008-11-14 |
15,000 |
Premium* |
|
Questcor Pharmaceuticals Inc |
QCOR |
See Remarks, Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Mallinckrodt plc |
MNK |
Director |
2016-03-16 |
139,149 |
2014-09-08 |
88,803 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-05-13 |
88,235 |
2016-05-13 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
Director |
2016-08-29 |
247,001 |
|
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2019-03-08 |
62,647 |
2024-02-08 |
158,801 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
129 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2011-10-10 |
4 |
S |
$31.43 |
$966,156 |
I/I |
(30,000) |
99,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2011-10-10 |
4 |
OE |
$0.44 |
$28,650 |
I/I |
30,000 |
129,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2011-12-09 |
4 |
S |
$43.18 |
$1,321,652 |
I/I |
(30,000) |
99,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2011-12-09 |
4 |
OE |
$0.44 |
$13,200 |
I/I |
30,000 |
129,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-04-10 |
4 |
OE |
$0.44 |
$13,200 |
I/I |
30,000 |
129,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-04-10 |
4 |
S |
$40.92 |
$1,227,600 |
I/I |
(30,000) |
99,500 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-05-04 |
4 |
GD |
$0.00 |
$0 |
I/I |
500 |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-06-11 |
4 |
S |
$45.37 |
$1,361,145 |
I/I |
(30,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-06-11 |
4 |
OE |
$0.44 |
$13,200 |
I/I |
30,000 |
129,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-07-10 |
4 |
OE |
$0.44 |
$137,174 |
I/I |
30,000 |
129,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-07-10 |
4 |
S |
$57.61 |
$1,730,377 |
I/I |
(30,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-08-27 |
4 |
S |
$43.07 |
$1,722,736 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-08-27 |
4 |
OE |
$5.09 |
$203,600 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-09-13 |
4 |
S |
$50.08 |
$2,003,186 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-09-13 |
4 |
OE |
$5.09 |
$203,600 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-12-19 |
4 |
OE |
$5.09 |
$305,400 |
I/I |
60,000 |
159,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2012-12-19 |
4 |
S |
$30.07 |
$1,809,112 |
I/I |
(60,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2013-02-15 |
4 |
S |
$30.00 |
$132,000 |
I/I |
(4,400) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2013-02-15 |
4 |
OE |
$5.09 |
$22,396 |
I/I |
4,400 |
103,400 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2013-02-19 |
4 |
S |
$30.13 |
$1,072,564 |
I/I |
(35,600) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President & CEO |
|
2013-02-19 |
4 |
OE |
$5.09 |
$181,204 |
I/I |
35,600 |
134,600 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
241,953 |
340,953 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-02-24 |
4/A |
A |
$0.00 |
$0 |
D/D |
241,930 |
291,317 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-02-24 |
4/A |
A |
$0.00 |
$0 |
D/D |
241,953 |
291,340 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-03-13 |
4 |
S |
$32.06 |
$641,260 |
I/I |
(20,000) |
99,000 |
0 |
- |
|
129 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|